Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 7 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, Dec 2025, Jan 2026, Feb 2026, Jun 2026, Jul 2026 and Aug 2026.
- Largest single sale: $13.5M (78,703 shares) of Axsome Therapeutics, Inc. on Jan 5, 2026. Filing
- Last sale before this period: Oct 8, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Axsome Therapeutics, Inc. (AXSM) | Chief Executive Officer, Director | Nov 19, 2015 | Aug 7, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 6, 2026, Axsome Therapeutics, Inc.: sold 4,660 shares for $997K, under a disclosed plan; 4,660 shares acquired by exercising options. 1 filing: 1
- Aug 5, 2026, Axsome Therapeutics, Inc.: sold 45,004 shares for $9.5M, under a disclosed plan; 45,004 shares acquired by exercising options. 1 filing: 1
- Jul 1, 2026, Axsome Therapeutics, Inc.: sold 49,666 shares for $11.9M, under a disclosed plan; 49,666 shares acquired by exercising options. 1 filing: 1
- Jun 9, 2026, Axsome Therapeutics, Inc.: sold 49,670 shares for $12.0M, under a disclosed plan; 49,670 shares acquired by exercising options. 1 filing: 1
- Feb 2, 2026, Axsome Therapeutics, Inc.: sold 32,410 shares for $6.0M, under a disclosed plan; 32,410 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.